SDH
PFE icon

Sloy Dahl & Holst’s Pfizer PFE Stock Holding History

Sloy Dahl & Holst’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$274K Hold
11,378
– – 0.03% 95
2026
Q1 		$319K Sell
11,378
-320
-3% -$8.52K 0.04% 85
2025
Q4 		$291K Sell
11,698
-516
-4% -$13K 0.04% 89
2025
Q3 		$311K Buy
12,214
+335
+3% +$8.27K 0.03% 87
2025
Q2 		$288K Buy
11,879
+205
+2% +$4.78K 0.04% 90
2025
Q1 		$296K Sell
11,674
-1,070
-8% -$28K 0.05% 78
2024
Q4 		$338K Buy
12,744
+352
+3% +$9.55K 0.04% 75
2024
Q3 		$359K Buy
12,392
+4,050
+49% +$118K 0.06% 68
2024
Q2 		$233K Buy
8,342
+925
+12% +$25.5K 0.05% 81
2024
Q1 		$206K Hold
7,417
– – 0.05% 83
2023
Q4 		$214K Buy
7,417
+521
+8% +$15.8K 0.04% 83
2023
Q3 		$229K Hold
6,896
– – 0.05% 74
2023
Q2 		$253K Hold
6,896
– – 0.05% 66
2023
Q1 		$281K Hold
6,896
– – 0.06% 55
2022
Q4 		$353K Sell
6,896
-511
-7% -$24.5K 0.12% 42
2022
Q3 		$324K Sell
7,407
-2,868
-28% -$139K 0.07% 54
2022
Q2 		$539K Hold
10,275
– – 0.13% 39
2022
Q1 		$531K Buy
10,275
+1,541
+18% +$80K 0.09% 39
2021
Q4 		$376K Hold
8,734
– – 0.08% 55
2021
Q3 		$376K Buy
8,734
+511
+6% +$22.6K 0.08% 55
2021
Q2 		$322K Buy
8,223
+135
+2% +$5.25K 0.04% 49
2021
Q1 		$293K Buy
8,088
+933
+13% +$33.1K 0.04% 51
2020
Q4 		$286K Buy
7,155
+1,353
+23% +$49.6K 0.14% 41
2020
Q3 		$204K Buy
+5,802
New +$203K 0.08% 37
2020
Q2 		– Sell
-8,068
Closed -$249K – 44
2020
Q1 		$249K Buy
8,068
+527
+7% +$18K 0.19% 31
2019
Q4 		$280K Buy
+7,541
New +$269K 0.26% 36

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Sloy Dahl & Holst's PFE Position: Q2 2026 in Review

Sloy Dahl & Holst held its Pfizer (PFE) position steady in Q2 2026 at 11,378 shares worth $274K. The position accounts for 0.03% of the portfolio, ranked #95.

Sloy Dahl & Holst first reported a position in PFE in Q4 2019 and has held it in 26 quarters since. The position peaked at $539K in Q2 2022. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Sloy Dahl & Holst held 11,378 shares of Pfizer worth $274K as of Q2 2026.
  • Sloy Dahl & Holst left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up 0.03% of Sloy Dahl & Holst's portfolio in Q2 2026, its #95 holding.
  • Sloy Dahl & Holst first reported a position in Pfizer in Q4 2019 and has held it in 26 quarters since.
  • Sloy Dahl & Holst's Pfizer position peaked at $539K in Q2 2022.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Sloy Dahl & Holst's 13F filing for Q2 2026, filed 13 Aug 2026.